HCA Healthcare, Inc.

NYSE:HCA

Medical - Care Facilities

Healthcare
$476.35 -3.10%

-$12.05 today

Market cap
$99.51B
Beta
1.13
P/E (TTM)
12.5
EPS (TTM)
$29.98
Dividend yield
0.80%
52W Low $330.00High $556.52

Volume 1.60M

Average 1.37M

HCA Selling, General & Admin

Overhead costs of running the business, including sales, marketing, management, and administrative staff.

HCA Healthcare, Inc.NYSE: HCA

Selling, General & Admin · Q2 FY2026 · quarter ended Jun 2026

Selling, general & admin growth accelerates

Q2 FY2026 selling, general & admin of $8.29B rose 5.5% year over year, ahead of the -47.6% change in trailing-twelve-month selling, general & admin. Sequentially, it rose 0.1% from the prior quarter. Over 3 fiscal years it compounded at -33.9% a year.

Context

  • Selling, general & admin amounted to 10.6% of revenue in FY2025, down 33.6 pp from a year earlier.
  • Selling, general & admin increased in 2 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether selling, general & admin reaches the consensus estimate from 18 analysts of $30.35B (+279.5%) for the fiscal year ending Dec 2026, a step up from the -74.3% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
$8.29B+0.1% QoQ
Last fiscal yearDec 2025
$8B-74.3% YoY
LTMJun 2026
$16.57B-47.6% YoY
Selling, General & Admin past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+5.5%——
1 year-74.3%+279.5%+353.8 pp
3-year CAGR-33.9%+59.9%+93.8 pp
5-year CAGR+35.8%—
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Selling, General & Admin history

USD · from the income statement

Latest · FY2025
8B USD
Year-over-year change
-74.3%
4-year CAGR
-26.1%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Selling, General & Admin vs competitors

How HCA compares with its peers on the latest reported figures

  • HCA's LTM Jun 2026 selling, general & admin of $16.57B is the highest of the 6 companies compared; the peer median is $6.61B.
  • Its year-over-year change of -47.6% is the lowest of 6, against a peer median of +23.2%.
  • Selling, general & admin amounts to 21.2% of revenue for HCA, versus a peer median of 32.0%.
HCA Competitors Peer median
Selling, General & Admin for HCA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
HCAHCA Healthcare, Inc.LTM Jun 2026$16.57B -47.6%-33.9%21.2%
CYHCommunity Health Systems, Inc.LTM Mar 2026$10.62B +3576.1%—49.5%
UHSUniversal Health Services, Inc.LTM Jun 2026$8.46B +6.7%+6.1%46.7%
THCTenet Healthcare CorporationLTM Jun 2026$6.61B +37.6%+176.5%30.3%
ARDTArdent Health Partners, LLCLTM Mar 2026$2.06B -42.1%-29.3%32.0%
PACSPACS Group, Inc.LTM Jun 2026$442.64M +23.2%+40.7%8.0%
Peer median (excluding HCA) $6.61B+23.2%+23.4%32.0%

Competitors are the stored peer set for HCA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue58.75B60.23B64.97B70.6B75.6B
Cost of Revenue36.26B37.06B39.39B41.93B44.23B
Gross Profit22.49B23.18B25.58B28.68B31.37B
Gross Margin38.3%38.5%39.4%40.6%41.5%
Research & Development00000
Selling, General & Admin26.78B27.69B29.49B31.17B8B
Operating Expenses12.81B14.12B15.95B18.13B19.41B
Depreciation & Amortization2.85B2.97B3.08B3.31B3.52B
EBITDA14.25B13.29B12.72B13.9B15.6B
EBITDA Margin24.3%22.1%19.6%19.7%20.6%
Operating Income9.68B9.05B9.63B10.55B11.97B
Operating Margin16.5%15.0%14.8%14.9%15.8%
Interest Income00000
Interest Expense1.53B1.74B1.94B2.06B2.25B
Other Income / Expenses155M(473M)(1.92B)(2.02B)(2.13B)
Income Before Tax9.83B8.58B7.71B8.52B9.83B
Pre-Tax Margin16.7%14.2%11.9%12.1%13.0%
Income Tax Expense2.11B1.75B1.62B1.87B2.05B
Net Income6.96B5.64B5.24B5.76B6.78B
Net Margin11.8%9.4%8.1%8.2%9.0%
EPS (Basic)21.5119.4419.2422.2728.62
EPS (Diluted)21.1619.1518.9622.0028.38
Weighted Avg Shares323.32M290.35M272.4M258.6M230.71M
Weighted Avg Shares (Diluted)328.75M294.67M276.41M261.81M230.71M

HCA Healthcare, Inc.

NYSE:HCA

Intrinsic Alpha fair value

Locked

Current Price

$476.35

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.